AzTrials
AzTrials

HypnosisHYPNINFNCT06419842

Impact of Hypnosis for Performing Lumbar Infusion Tests

A study testing hypnosis and comfort in people with Hypnosis and Hydrocephalus, run by Centre Hospitalier Universitaire, Amiens at 1 site in France.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

Infusion tests are now the gold standard for the diagnosis of chronic adult hydrocephalus (CAH), also known as normal pressure hydrocephalus. It is an invasive procedure using the same approach as a lumbar puncture. Read more about this study

Who is it for?
Ages 65 years and older
Conditions the study is for
Hypnosis, Hydrocephalus, Anxiety
What is being tested?
hypnosis and comfort
Could I receive a placebo?
Yes, some participants may receive a placebo
How many people
90 participants
Where
1 siteFrance
Study dates
14 May 2024to Jul 2026
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 65 years and older
  • All sexes
  • No healthy volunteers
  • Older adult

Who may be able to join

  • Patient over 65 years old undergoing assessment for suspected CAH in day hospitalization for a lumbar infusion test
  • No major cognitive impairment (MMSE>20)

Who cannot join

  • Patient less than 65 years old
  • Major cognitive impairment (MMSE<20)
  • History of lumbar surgery
  • Contraindication to lumbar puncture or infusion test
  • Hearing impairment

Trial locations and contacts

1 site in 1 country.

Laurence JANIAK, APRN contact

0322088943

janiak.laurence@chu-amiens.fr

France1 site, 1 recruiting
  • CHU Amiens Picardie

    Amiens, Picardie, 80054

    Laurence JANIAK, APRN, 0322088943, janiak.laurence@chu-amiens.fr

    Cyril CAPEL, MD

    Recruiting

Other trials in France

About this study

Official title: Evaluation of the Impact of Hypnosis for Performing Lumbar Infusion Tests.

Infusion tests are now the gold standard for the diagnosis of chronic adult hydrocephalus (CAH), also known as normal pressure hydrocephalus. It is an invasive procedure using the same approach as a lumbar puncture. Once the intrathecal puncture is performed, the intracranial pressure is measured in lateral decubitus via a pressure head. Dynamic tests (injection of 0.9% NaCl at a constant flow rate) are performed after recording the basal pressure. This type of test lasts 30 to 45 minutes in lateral decubitus. Patients with CAH have cognitive-behavioral disorders that can alter the gesture and its interpretation in case of movements or contractures. Movement artefacts lead to a longer recording time. The longer the test, the more the patients' tolerance tends to decrease. Moreover, the patient's feeling towards this test is important because it may have to be repeated. Pain, anxiety and patient comfort are essential parameters to consider. Non-medicinal techniques (hypnosis, music therapy) have shown a tendency to reduce anxiety in pediatric and adult populations with an impact on instantaneous anxiety but also on personality-related anxiety. Most studies are focused on specific pathologies, primarily in palliative care, or on pediatric application. The use of these techniques in an elderly population with mild cognitive-behavioral disorders has not been explored.

The objective is to evaluate the impact of hypnosis on anxiety, pain and comfort during the lumbar infusion test.

Being tested
hypnosis, comfort
Keywords
hypnosis, infusion study, Hydrocephalus, Anxiety, Pain
Medical subject headings
Hydrocephalus, Anxiety Disorders, Pain

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • hypnosisOther

    the patient benefits from a dedicated nurse consultation. During this consultation, the nurse will explain the highlights of the hospitalization, the procedure and anticipate the hypnosis technique to be used. The technique chosen during the consultation will be applied during the test. The nurse is positioned at the head of the patient and with physical contact.

  • comfortOther

    the patient benefits from a nurse consultation. Non-medicinal techniques are not offered. During the infusion test, the nurse will be positioned at the patient's head allowing proximity but without oral or physical intervention.

Study groups in NCT06419842
Study groupRoleWhat they receive
hypnosisExperimentalIn group 1, the patient benefits from a dedicated nurse consultation. During this consultation, the nurse will explain the highlights of the hospitalization, the procedure and anticipate the hypnosis technique to be used. The technique chosen during the consultation will be applied during the test. The nurse is positioned at the head of the patient and with physical contact.
Receives: Other: hypnosis
comfortSham comparatorIn group 2, the patient benefits from a nurse consultation. Non-medicinal techniques are not offered. During the infusion test, the nurse will be positioned at the patient's head allowing proximity but without oral or physical intervention.
Receives: Other: comfort
standardNo interventionIn group 3, the IDE consultation is performed according to the same modalities as in group 2. During the procedure, the nurse will be out of the patient's field of vision and will assist the surgeon in the installation behind the patient. Only the surgeon will interact with the patient.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Decrease in anxiety in group 1compared to the other groups

    Decrease in anxiety in group 1 compared to the other groups

    Measured: 2 years

Secondary outcomes (6)
  1. Decrease in pain in group 1

    Decrease in pain on the numerical scale in group 1 versus other groups

    Measured: 2 years

  2. Increase in comfort in group 1

    Increase in comfort on the numerical scale in group 1 versus the other groups

    Measured: 2 years

  3. Better overall patient impression in group 1 versus other groups

    Better overall patient impression (Likert scale) in group 1 versus other groups

    Measured: 2 years

  4. Less heart rate variation in group 1 versus other groups

    Less heart rate variation in group 1 versus other groups

    Measured: 2 years

  5. Decreased puncture time required in group 1 versus other groups

    Decreased puncture time required in group 1 versus other groups

    Measured: 2 years

  6. fewer position changes required in group 1 versus other groups

    fewer position changes required in group 1 versus other groups

    Measured: 2 years

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted17 May 2024
  2. Study start14 May 2024
  3. Primary completionMay 2026 (estimated)
  4. Study completionJul 2026 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Other
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Participant
Enrolment
90 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06419842
Sponsor's protocol ID
PI2023_843_0149
Acronym
HYPNINF
Status last verified
May 2024
First submitted
14 May 2024
Last updated
22 May 2024
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing hypnosis and comfort in people with Hypnosis and Hydrocephalus, run by Centre Hospitalier Universitaire, Amiens at 1 site in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 22 May 2024. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Laurence JANIAK, APRN (0322088943, janiak.laurence@chu-amiens.fr), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Decrease in anxiety in group 1compared to the other groups (time frame: 2 years). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 22 May 2024.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in